Mebendazole tablets (anthelmintic)
Recently
discontinued from the US market (October 27, 2011); Teva Pharmaceuticals was
the sole manufacturer for mebendazole and no statement for the discontinuation
was provided. Other anthelmintics
(abendazole, ivermectin, praziquantel, pyrantel) are still available (no active
shortages).
Mebendazole Indication
|
Alternative Treatment
|
Hookworm (A. duodenale, N.
americanus)
|
1st line: Albendazole, pyrantel
|
Roundworm (A. lumbricoides)
|
1st line: Albendazole, pyrantel
2nd line: Nitazoxanide, ivermectin
|
Pinworm (E. vermicularis)
|
1st line: Albendazole, pyrantel
2nd line: Ivermectin
|
Whipworm (T. trichiura)
|
1st line: Albendazole
2nd line: Ivermectin
|
Capillariasis (C.
phillipinensis; unlabeled use)
|
1st line: Albendazole
|
Giardiasis (G. duodenalis;
unlabeled use)
|
1st line: Metronidazole, tinidazole, nitazoxanide
2nd line: Albendazole, paromomycin
|
Filarasis (M. perstans;
unlabeled use)
|
1st line: Albendazole
|
Visceral larva migrans (Toxocariasis; unlabeled use)
|
1st line: Albendazole
|
Resources:
1. American
Society of Health-System Pharmacists. “Drug shortages: Discontinued Drugs.” http://www.ashp.org/DrugShortages/NotAvailable/.
Accessed April 22, 2012.
2. American
Society of Health-System Pharmacists. “Drug shortages: Current Drugs.” http://www.ashp.org/DrugShortages/Current/.
Accessed April 22, 2012.
3. American
Academy of Pediatrics. Red Book:
2009 Report of the Committee on Infectious Diseases. 28th Edition.
Elk Grove Village, IL: American Academy of Pediatrics;2009.
4. Wilson
CM and Freedman DO. “Antiparasitic Agents.” Principles and
Practice of Pediatric Infectious Diseases. 3rd Edition.
Philidephia, PA:Elsevier, Inc.; 2008.
No comments:
Post a Comment